Below are the most recent publications written about "Viral Proteins" by people in Profiles.
-
Tran TCG, Than TT, Lai TNH, Le HD, Nguyen TT, Vu ND, Ngo NBA, Nguyen HT, Nguyen PA, Goonewardene K, Ambagala A, Le VP. Emergence of Non-Hemadsorbing African Swine Fever Virus Genotype II Variants and the Evolution of a Vaccine-Derived Strain in Vietnam. Viruses. 2026 May 26; 18(6).
-
McKitterick AC, Lyerly EW, Bernhardt TG. Bacteriophages target membrane-anchored glycopolymers to promote host cell lysis and progeny release. Proc Natl Acad Sci U S A. 2026 Apr 28; 123(17):e2606687123.
-
Mala P, Banerjee R, Abek A, Forster Iii J, Pinjari A, Kulkarni AA, Martin CT. A novel plasmid-based co-tethered transcription platform for high yield, high purity mRNA synthesis. Nucleic Acids Res. 2025 Nov 26; 53(22).
-
Yu C, Wang C, Forman T, Xie J, Major S, Fang MX, Voyer JE, Pogliano J, Fu TM. Phage SSB detection by retron Eco8 msDNA unleashes nuclease-mediated immunity. Mol Cell. 2025 Nov 20; 85(22):4243-4253.e4.
-
Roddy K, Grzesik P, Smith BJ, Ko N, Vashee S, Desai PJ. The loss of both pUL16 and pUL21 in HSV-1-infected cells alters capsid-tegument composition, nuclear membrane architecture, cytoplasmic maturation and cell-to-cell spread. J Gen Virol. 2025 03; 106(3).
-
Azzolino VN, Shaqra AM, Ali A, Kurt Yilmaz N, Schiffer CA. Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease. Viruses. 2025 01 08; 17(1).
-
MalagodaPathiranage K, Banerjee R, Martin CT. A new approach to RNA synthesis: immobilization of stably and functionally co-tethered promoter DNA and T7 RNA polymerase. Nucleic Acids Res. 2024 09 23; 52(17):10607-10618.
-
Azzolino VN, Shaqra AM, Ali A, Kurt Yilmaz N, Schiffer CA. Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance. Viruses. 2024 09 05; 16(9).
-
Weaver GC, Schneider CL, Becerra-Artiles A, Clayton KL, Hudson AW, Stern LJ. The HHV-6B U20 glycoprotein binds ULBP1, masking it from recognition by NKG2D and interfering with natural killer cell activation. Front Immunol. 2024; 15:1363156.
-
Muniraju M, Mutsvunguma LZ, Reidel IG, Escalante GM, Cua S, Musonda W, Calero-Landa J, Farelo MA, Rodriguez E, Li Z, Ogembo JG. Kaposi sarcoma-associated herpesvirus complement control protein (KCP) and glycoprotein K8.1 are not required for viral infection in vitro or in vivo. J Virol. 2024 06 13; 98(6):e0057624.